P00268 (RUBR_CLOPA) Clostridium pasteurianum

Rubredoxin UniProtKBInterProInteractive Modelling

54 aa; Sequence (Fasta) ; 1 identical sequence: Clostridium pasteurianum DSM 525 = ATCC 6013: A0A0H3JBJ6

Available Structures

45 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal Structure of CC Chemokine Receptor 5 (CCR5) in complex with high potency HIV entry inhibito…
5uiw
 Heteromer
P13501; P51681; 		1-54
1×ZN; 6×OLC; 2×OLA;
Assess
Structure of apelin receptor in complex with agonist peptide
5vbl
 Heteromer
P35414; 		1-54
1×ZN; 1×OLC;
Assess
Apelin receptor in complex with single domain antibody
6knm
 Heteromer
P35414; 		1-54
1×ZN;
Assess
Crystal structure of full length human GLP1 receptor in complex with Fab fragment (Fab7F38)
6ln2
 Heteromer
P43220; 		1-54
1×NAG; 1×ZN; 1×97Y;
Assess
XFEL crystal structure of human melatonin receptor MT2 in complex with 2-phenylmelatonin
6me6
 Heteromer
P0ABE7; P49286; 		1-53
2×JEY; 1×ZN; 1×OLC;
Assess
CLOSTRIDIUM PASTEURIANUM RUBREDOXIN C42S MUTANT
1be7
homo-3-mer1-54
3×FE;
Assess
RUBREDOXIN (OXIDIZED, FE(III)) AT 1.1 ANGSTROMS RESOLUTION
1iro
homo-3-mer1-53
3×FE;
Assess
RUBREDOXIN (ZN-SUBSTITUTED) AT 1.2 ANGSTROMS RESOLUTION
1irn
homo-3-mer1-53
3×ZN;
Assess
RUBREDOXIN V44A CP
1c09
homo-3-mer1-53
3×FE;
Assess
COMBINED CRYSTALLOGRAPHIC REFINEMENT AND ENERGY MINIMIZATION OF RUBREDOXIN AT 1.2 ANGSTROM RESOLUTI…
5rxn
monomer1-54
1×FE;
Assess
CRYSTALLOGRAPHIC REFINEMENT OF RUBREDOXIN AT 1.2 ANGSTROMS RESOLUTION
4rxn
monomer1-54
1×FE;
Assess
Crystal Structure of Cp Rd L41A mutant in oxidized state
1smm
monomer1-54
1×SO4; 1×FE;
Assess
Crystal Structure of Cp Rd L41A mutant in reduced state 2 (soaked)
1smw
monomer1-54
1×FE2;
Assess
Crystal Structure of Cp Rd L41A mutant in reduced state 1 (drop-reduced)
1smu
monomer1-54
1×FE2;
Assess
CLOSTRIDIUM PASTEURIANUM RUBREDOXIN G10A MUTANT
1b13
monomer1-54
1×FE;
Assess
Crystal Structure of V44A, G45P Cp Rubredoxin
1t9p
monomer1-54
1×FE;
Assess
CLOSTRIDIUM PASTEURIANUM RUBREDOXIN G43A MUTANT
1b2j
monomer1-54
1×FE;
Assess
CLOSTRIDIUM PASTEURIANUM RUBREDOXIN G10VG43A MUTANT
1b2o
monomer1-54
1×FE;
Assess
The human P2Y1 receptor in complex with BPTU
4xnv
monomer1-54
1×BUR; 1×CLR; 3×Y01; 8×OLC; 1×1PE; 1×ZN;
Assess
Crystal structure of human apo-Frizzled4 receptor
6bd4
monomer1-54
1×ZN; 4×OLC; 5×OLA; 3×SO4; 4×UNX;
Assess
Crystal structure of the human thromboxane A2 receptor bound to ramatroban
6iiu
monomer1-54
1×A8X; 1×ZN; 1×CLR; 2×OLC; 1×GOL;
Assess
Crystal structure of the human chemokine receptor CCR5 in complex with MIP-1a
7f1t
monomer1-54
1×ZN;
Assess
CRYSTAL STRUCTURE OF CCR2A IN COMPLEX WITH MK-0812
6gpx
monomer1-54
1×ZN; 11×OLA; 1×F7N;
Assess
Crystal structure of Apelin receptor in complex with small molecule
7sus
monomer1-54
1×ZN; 1×8EH; 1×OLC;
Assess
The human P2Y1 receptor in complex with MRS2500
4xnw
monomer1-54
1×2ID; 1×ZN;
Assess
Crystal Structure of the CCR5 Chemokine Receptor
4mbs
monomer1-54
1×MRV; 1×ZN; 6×OLC;
Assess
The Crystal structure of Human Chemokine Receptor CCR5 in complex with compound 34
6aky
monomer1-54
1×ZN; 1×OLC; 1×A4X;
Assess
The Crystal structure of Human Chemokine Receptor CCR5 in complex with compound 21
6akx
monomer1-54
1×ZN; 1×NO3; 1×A4R;
Assess
Crystal structure of the human thromboxane A2 receptor bound to daltroban
6iiv
monomer1-54
1×A90; 1×ZN; 1×CLR; 1×GOL;
Assess
CRYSTAL STRUCTURE OF CCR2A IN COMPLEX WITH MK-0812
6gps
monomer1-54
1×ZN; 1×F7N;
Assess
SOLUTION STRUCTURE OF REDUCED CLOSTRIDIUM PASTEURIANUM RUBREDOXIN, NMR, 20 STRUCTURES
1bfy
monomer1-54
1×FE;
Assess
X-RAY CRYSTAL STRUCTURE OF OXIDIZED RUBREDOXIN
1fhh
monomer1-53
1×FE;
Assess
X-RAY CRYSTAL STRUCTURE OF REDUCED RUBREDOXIN
1fhm
monomer1-53
1×FE2;
Assess
cadmium-substituted rubredoxin
1r0i
monomer1-53
1×CD;
Assess
mercury-substituted rubredoxin
1r0g
monomer1-53
1×HG;
Assess
Gallium-substituted rubredoxin
1r0f
monomer1-53
1×GA;
Assess
cobalt-substituted rubredoxin
1r0h
monomer1-53
1×CO;
Assess
Crystal Structure of V44L Cp Rubredoxin
1t9q
monomer1-53
1×FE;
Assess
Crystal Structure of V44G Cp Rubredoxin
1t9o
monomer1-53
1×FE;
Assess
nickel-substituted rubredoxin
1r0j
monomer1-53
1×NI;
Assess
Crystal structure of GPR52 ligand free form with rubredoxin fusion
6li2
monomer2-54
1×ZN; 11×OLC; 1×PEG;
Assess
XFEL crystal structure of human melatonin receptor MT2 (N86D) in complex with 2-phenylmelatonin
6me8
monomer1-53
1×JEY; 1×ZN;
Assess
XFEL crystal structure of human melatonin receptor MT2 (H208A) in complex with 2-phenylmelatonin
6me7
monomer1-53
1×JEY; 1×ZN;
Assess
XFEL crystal structure of human melatonin receptor MT2 in complex with ramelteon
6me9
monomer1-53
1×JEV; 1×ZN;
Assess
NMR and X-ray Analysis of Structural Additivity in Metal Binding Site-Swapped Hybrids of Rubredoxin
2pve
monomer1-52
1×ZN; 2×ACT;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4rxn.1.Amonomer0.831-54
1×FE;94.44
Assess